Drug profile · INN
valoctocogene roxaparvovec
ROCTAVIAN
valoctocogene roxaparvovec (ROCTAVIAN) is a coagulation factor ix exogenous protein. Associated with BioMarin Pharmaceutical Australia Pty Ltd.
EMA: approved Blood and blood forming organs (B02) B02BD15
Patents linked 0
Pipeline programs 4
News articles 1
Drug details — valoctocogene roxaparvovec
- Class
- Blood and blood forming organs (B02)
- Route
- —
- Patents
- 0
- Programs
- 4
- Data quality
- 0.89
Quick answer
valoctocogene roxaparvovec (ROCTAVIAN) is a coagulation factor ix exogenous protein. Associated with BioMarin Pharmaceutical Australia Pty Ltd.
Key facts
INN valoctocogene roxaparvovec
Brand ROCTAVIAN
Mechanism Coagulation factor IX exogenous protein
Target Coagulation factor IX
Therapeutic class Blood and blood forming organs (B02)
ATC code B02BD15
Originator BioMarin Pharmaceutical Australia Pty Ltd
Mechanism of action
Coagulation factor IX exogenous protein
Primary target: Coagulation factor IX
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Recent coverage
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is valoctocogene roxaparvovec?
valoctocogene roxaparvovec (ROCTAVIAN) is a coagulation factor ix exogenous protein. Associated with BioMarin Pharmaceutical Australia Pty Ltd.
What is the brand name for valoctocogene roxaparvovec?
ROCTAVIAN is a marketed brand name for valoctocogene roxaparvovec. Check FDA Drugs@FDA for the current US label holder and prescribing information.